Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (32) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Summaries of opinion (19) Apply Summaries of opinion filter Withdrawn applications (37) Apply Withdrawn applications filter Referrals (18) Apply Referrals filter Direct healthcare professional communication (26) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (9) Apply Yes filter

Authorisation status

Authorised (576) Apply Authorised filter Refused (2) Apply Refused filter Withdrawn (85) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (18) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (146) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (1) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (33) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (14) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (124) Apply Positive filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Biosimilar (79) Apply Biosimilar filter Orphan medicine (446) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

986 results

Remove all filtersRemove all filters

Medicine type Additional monitoring Remove Additional monitoring filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Accelerated assessment Remove Accelerated assessment filter

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Categories Human Remove Human filter

Sort by

List item

Human medicine European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya) (updated)

clopidogrel (as hydrochloride),
Date of authorisation: 20/09/2009, , Revision: 12, Authorised, Last updated: 30/07/2021
List item

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , Revision: 10, Authorised, Last updated: 30/07/2021
List item

Human medicine European public assessment report (EPAR): Mysildecard (updated)

sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016, , Revision: 4, Authorised, Last updated: 30/07/2021
List item

Human medicine European public assessment report (EPAR): Trumenba (updated)

Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B, Meningitis, Meningococcal
Date of authorisation: 24/05/2017, , Revision: 10, Authorised, Last updated: 30/07/2021
List item

Human medicine European public assessment report (EPAR): Azacitidine Accord (updated)

azacitidine, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020, , Revision: 2, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Matever (updated)

levetiracetam, Epilepsy
Date of authorisation: 03/10/2011, , Revision: 23, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Flucelvax Tetra (updated)

A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Washington/19/2020, wild type); A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, wild type); B/Washington/02/2019-like strain (B/Darwin/7/2019, wild type); B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type), Influenza, Human
Date of authorisation: 12/12/2018, , Revision: 9, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Sarclisa (updated)

Isatuximab, Multiple Myeloma
Date of authorisation: 30/05/2020, , Revision: 2, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Blenrep (updated)

belantamab mafodotin, Multiple Myeloma
Date of authorisation: 25/08/2020, , , , Revision: 2, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Iclusig (updated)

ponatinib, Leukemia, Myeloid, Leukemia, Lymphoid
Date of authorisation: 01/07/2013, , , , Revision: 21, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Nerlynx (updated)

neratinib, Breast Neoplasms
Date of authorisation: 31/08/2018, , Revision: 7, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020, , , Revision: 10, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Fluad Tetra (updated)

A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019 IVR‐215) A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Cambodia/e0826360/2020 IVR‐224) B/Washington/02/2019 – like strain (B/Victoria/705/2018 BVR‐11) B/Phuket/3073/2013 – like strain (B/Phuket/3073/2013 BVR‐1B), Influenza, Human
Date of authorisation: 20/05/2020, , Revision: 2, Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Ryeqo (updated)

Relugolix, norethisterone acetate, estradiol hemihydrate, Leiomyoma
Date of authorisation: 16/07/2021, , Authorised, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited) (updated)

pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 24/04/2017, , Revision: 7, Withdrawn, Last updated: 29/07/2021
List item

Human medicine European public assessment report (EPAR): Bylvay (updated)

Odevixibat, Cholestasis, Intrahepatic
Date of authorisation: 16/07/2021, , , , Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Taltz (updated)

ixekizumab, Psoriasis
Date of authorisation: 25/04/2016, , Revision: 13, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Maviret (updated)

glecaprevir, pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017, , , Revision: 13, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Wakix (updated)

pitolisant, Narcolepsy
Date of authorisation: 31/03/2016, , , Revision: 11, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Respreeza (updated)

Human alpha1-proteinase inhibitor, Genetic Diseases, Inborn, Lung Diseases
Date of authorisation: 20/08/2015, , Revision: 9, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Orphacol (updated)

cholic acid, Digestive System Diseases, Metabolism, Inborn Errors
Date of authorisation: 12/09/2013,
Date of refusal: 25/05/2012, , , , Revision: 10, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Orkambi (updated)

Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 18/11/2015, , Revision: 25, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Rekambys (updated)

rilpivirine, HIV Infections
Date of authorisation: 17/12/2020, , Revision: 1, Authorised, Last updated: 28/07/2021
List item

Human medicine European public assessment report (EPAR): Imfinzi (updated)

durvalumab, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 21/09/2018, , Revision: 8, Authorised, Last updated: 27/07/2021
List item

Human medicine European public assessment report (EPAR): Skysona (updated)

elivaldogene autotemcel, Adrenoleukodystrophy
Date of authorisation: 16/07/2021, , , Authorised, Last updated: 27/07/2021